Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/30/2012US20120220524 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
08/30/2012US20120219643 Anti-neoplastic compositions comprising extracts of black cohosh
08/30/2012US20120219632 Methods for monitoring cellular states and for immortalizing mesenchymal stem cell
08/30/2012US20120219624 Process for preparing products comprising stabilised actives and compositions comprising same
08/30/2012US20120219620 SCF Extract Containing Cardiac Glycoside
08/30/2012US20120219617 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
08/30/2012US20120219615 Therapeutic Use of a TLR Agonist and Combination Therapy
08/30/2012US20120219614 Methods and compositions for preventing a condition
08/30/2012US20120219601 Composition Comprising Biodegradable Hydrating Ceramics for Controlled Drug Delivery
08/30/2012US20120219600 Polymer conjugated protein micelles
08/30/2012US20120219597 Pharmaceutical formulations for indibulin
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219572 Spheroidal Aggregates of Mesenchymal Stem Cells
08/30/2012US20120219571 Combination motif immune stimulatory oligonucleotides with improved activity
08/30/2012US20120219570 G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker
08/30/2012US20120219569 Use of an anti-cd151 antibody in the treatment of cancer
08/30/2012US20120219568 Epidithiodioxopiprazines and uses thereof in treating cancer
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219563 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment
08/30/2012US20120219561 Prophylaxis Against Cancer Metastasis
08/30/2012US20120219560 DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
08/30/2012US20120219559 Methods of modulating immune function
08/30/2012US20120219554 Extracellular yaluronidase from streptomyces koganeiensis
08/30/2012US20120219551 Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
08/30/2012US20120219550 Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
08/30/2012US20120219549 Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor
08/30/2012US20120219548 PODXL Protein in Colorectal Cancer
08/30/2012US20120219547 Humanized Anti-TNFalpha Antibodies
08/30/2012US20120219541 Therapeutic Compositions Comprising Monoterpenes
08/30/2012US20120219524 Antibodies that bind colony stimulating factor 1 receptor (csf1r)
08/30/2012US20120219522 Substituted quinoline compounds and methods of use
08/30/2012US20120219514 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
08/30/2012US20120219506 Catenae: Serosal Cancer Stem Cells
08/30/2012US20120219504 Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof
08/30/2012US20120219503 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/30/2012US20120219502 Methods and compositions for targeting gc1qr/p32
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012CA2828253A1 Polymer conjugated protein micelles
08/30/2012CA2828251A1 2-amino-naphthyridine derivatives
08/30/2012CA2828133A1 Bisphosphonate-prodrugs
08/30/2012CA2828122A1 Cancer diagnosis and treatment
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/30/2012CA2826892A1 Phosphorus containing compounds as protein kinase inhibitors
08/30/2012CA2826651A1 Substituted aromatic sulfur compounds and methods of their use
08/30/2012CA2825972A1 Muc1 based glycolipopeptide vaccine with adjuvant
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2492264A2 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
08/29/2012EP2492261A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer
08/29/2012EP2491953A2 Optical imaging contrast agent, use and device thereof
08/29/2012EP2491951A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient
08/29/2012EP2491944A2 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
08/29/2012EP2491925A1 Antitumoral combination comprising cabazitaxel and cisplatin
08/29/2012EP2491923A2 Combinations of therapeutic agents for treating cancer
08/29/2012EP2491919A1 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof
08/29/2012EP2491123A2 Single molecule nucleic acid nanoparticles
08/29/2012EP2491058A1 Modulators of hepatocyte growth factor activator
08/29/2012EP2491057A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
08/29/2012EP2491043A2 2,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors
08/29/2012EP2491041A2 Bivalent diazo bicyclic smac mimetics and the uses thereof
08/29/2012EP2491039A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
08/29/2012EP2491037A1 Compounds
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491032A1 Akt inhibitors
08/29/2012EP2491027A1 Salts of imatinib with tartaric acids
08/29/2012EP2491025A1 Azaazulene compounds
08/29/2012EP2491016A1 Substituted benzosulphonamides
08/29/2012EP2491015A1 Substituted benzosulphonamides
08/29/2012EP2491014A1 Substituted halophenoxybenzamide derivatives
08/29/2012EP2490766A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
08/29/2012EP2490723A1 Nanoparticles for drug delivery
08/29/2012EP2490711A1 A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
08/29/2012EP2490693A1 PYRAZOLO [3,4-b]PYRIDIN-4-ONE KINASE INHIBITORS
08/29/2012EP2490690A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
08/29/2012EP2490689A2 Injectable formulations for intra- articular or peri-articular administration
08/29/2012EP2490688A1 Combination cancer therapy with hsp90 inhibitory compounds
08/29/2012EP2490684A2 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
08/29/2012CN1948275B Verakanol Mannich alkali derivative, its preparation method and use
08/29/2012CN1924021B Gene recombination humanized pigment epithelium derivative factor and application therof
08/29/2012CN1735435B Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same
08/29/2012CN1678633B Anti-IGF-I receptor antibody
08/29/2012CN1636594B Angiostatin and use of the same for inhibition of angiogenesis
08/29/2012CN102649978A Application of CCDC158 gene in preparation of drugs for treating or diagnosing liver cancer
08/29/2012CN102649963A Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer
08/29/2012CN102649841A Polyethylene glycol-modified phospholipid derivative taking anilino-quinazoline as targeting ligand and preparation method thereof
08/29/2012CN102649824A Method for separating anti-tumor polysaccharide component from black fungus by applying radial chromatography
08/29/2012CN102649821A Method for extracting polyose and terpenoide from pinecones
08/29/2012CN102649814A Earthworm protein with HBeAg degrading enzyme activity and application thereof
08/29/2012CN102649810A Camptothecin derivative and preparation method and application thereof
08/29/2012CN102649795A 10-methoxyl camptothecin derivative, preparation method and application
08/29/2012CN102649787A (benzimidazole-2-yl)pyridine derivative and application thereof to preparation of anticoagulant medicines
08/29/2012CN102649778A Quinazoline derivative and purposes thereof in preparing antineoplastic drugs
08/29/2012CN102649773A Amino aromatic hydrocarbon compound and application thereof to preparation of medicine for resisting malignant tumor
08/29/2012CN102649765A Emodin di-n-octyl quaternary ammonium salt with anti-leukemia activity and preparation method thereof
08/29/2012CN102649750A Curcumin salicylic acid monoester and synthesis method thereof and application curcumin salicylic acid monoester to anti-tumor and anti-inflammatory aspects
08/29/2012CN102649711A Extracting method for drumstick phenanthrene
08/29/2012CN102648956A Traditional Chinese herbal medicament for treating breast cancer and preparation method thereof
08/29/2012CN102648945A Chinese medicinal formula for treating hysteromyoma
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 2211